Back to Agenda
Session 6 Track 4 - Technology Considerations for Next Generation RIM solutions
Session Chair(s)
Jake Doran
Vice President, Digital
Lykos Therapeutics, United States
Technology innovation in the RIM space has not been as transformational over the years as what we have seen in other areas, i.e. Clinical, Safety, etc. Is this paradigm about to change? What is industry doing to address the current needs around information and what are the strategic decisions that come from having a clear vision into RIM data? We will take an in-depth look at the value of regulatory data and how it is now being viewed as a strategic corporate asset. We will then transition in to a discussion around disruptive technologies and how technology has driven the transformation in other verticals and then finally take an in-depth look at the current state of the technology available in the RIM space and evaluate what is needed in order to be successful in the future. Are we on the cusp of the next generation of RIM tools?
Learning Objective : 1. Identify challenges in collecting and managing high-quality regulatory information 2. Compare and contrast with best practices in other verticals such as banking and financial sectors 3. Highlight considerations to treat regulatory information as a corporate asset
Speaker(s)
Regulatory Information: (Un)necessary Evil or Corporate Asset?
Venkatraman Balasubramanian, PhD, MBA
VB Insights, LLC, United States
Healthcare and Life Sciences Strategic Advisor
Digital Health Impact on Regulatory and RIM
Michael Sauter
United States
Senior Director, Global Regulatory Operations
Achieving a Future State RIM Solution
John Jones
Independent Contractor, United States
Have an account?